Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2011, Article ID 495201, 4 pages
http://dx.doi.org/10.1155/2011/495201
Case Report

Isolated Central Nervous System Vasculitis Associated with Antiribonuclear Protein Antibody

1Baton Rouge Neurology Associates, Baton Rouge General Medical Center, Baton Rouge, LA 70806, USA
2Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390-7208, USA

Received 23 May 2011; Accepted 20 June 2011

Academic Editors: A. Atri, T. K. Banerjee, and Y. Narita

Copyright © 2011 Amer M. Awad and Mathew Stevenson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Matsui, F. Udaka, M. Oda, T. Kubori, K. Nishinaka, and M. Kameyama, “Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease,” Neurology India, vol. 54, no. 1, pp. 83–85, 2006. View at Google Scholar · View at Scopus
  2. S. D. Prystowsky, “Mixed connective tissue disease,” Western Journal of Medicine, vol. 132, no. 4, pp. 288–293, 1980. View at Google Scholar
  3. S. E. Nadeau, “Neurologic manifestations of connective tissue disease,” Neurologic Clinics, vol. 20, no. 1, pp. 151–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Salmhofer, J. Hermann, M. Joch, H. Kerl, and W. Graninger, “High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 8, pp. 1047–1053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Alarcon-Segovia and M. Villarreal, “Classification and diagnostic criteria for mixed connective tissue disease,” in Mixed Connective Tissue Diseases and Antinuclear Antibodies, R. Kasukawa and G. C. Sharp, Eds., pp. 33–40, Elsevier, Amsterdam, The Netherlands, 1987. View at Google Scholar
  6. G. C. Sharp et al., “Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA),” American Journal of Medicine, vol. 52, pp. 148–159, 1972. View at Google Scholar
  7. M. Aringer and J. S. Smolen, “Mixed connective tissue disease: what is behind the curtain?” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 6, pp. 1037–1049, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. C. Sharp, “Diagnostic criteria for classification of mixed connective tissue disease,” in Mixed Connective Tissue Disease and Antinuclear Antibodies, R. Kasukawa and G. C. Sharp, Eds., pp. 23–32, Elsivier, Amsterdam, The Netherlands, 1987. View at Google Scholar
  9. A. Doria, A. Ghirardello, P. de Zambiasi, A. Ruffatti, and P. F. Gambari, “Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients,” Journal of Rheumatology, vol. 19, no. 2, pp. 259–264, 1992. View at Google Scholar · View at Scopus
  10. E. L. Greidinger and R. W. Hoffman, “Autoantibodies in the pathogenesis of mixed connective tissue disease,” Rheumatic Disease Clinics of North America, vol. 31, no. 3, pp. 437–450, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Burdt, R. W. Hoffman, S. L. Deutscher, G. S. Wang, J. C. Johnson, and G. C. Sharp, “Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings,” Arthritis and Rheumatism, vol. 42, no. 5, pp. 899–909, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Migliorini, C. Baldini, V. Rocchi, and S. Bombardieri, “Anti-Sm and anti-RNP antibodies,” Autoimmunity, vol. 38, no. 1, pp. 47–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. P. Keith, C. Moratz, and G. C. Tsokos, “Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease,” Autoimmunity Reviews, vol. 6, no. 4, pp. 232–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. N. S. Gendi, K. I. Welsh, W. J. Van Venrooij, R. Vancheeswaran, J. Gilroy, and C. M. Black, “HLA type as a predictor of mixed connective tissue disease differentiation: ten-year clinical and immunogenetic followup of 46 patients,” Arthritis and Rheumatism, vol. 38, no. 2, pp. 259–266, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. D. S. Younger, A. P. Hays, J. C. M. Brust, and L. P. Rowland, “Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology,” Archives of Neurology, vol. 45, no. 5, pp. 514–518, 1988. View at Google Scholar · View at Scopus
  16. D. S. Younger, “Vasculitis of the nervous system,” Current Opinion in Neurology, vol. 17, no. 3, pp. 317–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Pipitone and C. Salvarani, “Role of imaging in vasculitis and connective tissue diseases,” Best Practice and Research: Clinical Rheumatology, vol. 22, no. 6, pp. 1075–1091, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. F. Duna and L. H. Calabrese, “Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system,” Journal of Rheumatology, vol. 22, no. 4, pp. 662–667, 1995. View at Google Scholar · View at Scopus
  19. W. Küker, “Cerebral vasculitis: imaging signs revisited,” Neuroradiology, vol. 49, no. 6, pp. 471–479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Sato, T. Fujii, T. Yokoyama et al., “Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease,” Arthritis Care and Research, vol. 62, no. 12, pp. 3730–3740, 2010. View at Publisher · View at Google Scholar